Advertisement

115 patients with first cadaver kidney transplants followed two to seven and a half years

A multifactorial analysis
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      One hundred fifteen consecutive patients received first transplants from cadaver donors at the University of Minnesota between January 1, 1968, and May 31, 1973. All patients have been followed for at least two years. The two-year survival rate is 70 per cent and the two-year transplant function rate is 58 per cent. Considerable improvement in both patient survival and transplant function has been noted since 1971. The success of transplantation appears to depend to a large degree on the age of the transplant recipient, the number of HLA antigens matched between donor and recipient, and the dose of antilymphoblast globulin (ALG) administered to the recipient during the first two weeks after transplantation. Each of these factors appears to be important even when the other factors are controlled, and when patients with diabetes, suffering technical failure or hyperacute rejection, are excluded. The results utilizing well-matched cadaver kidneys plus large doses of ALG appear to be equivalent to those obtained with the use of mismatched kidneys from relatives, but further analysis will be required to draw a definite conclusion. Patients receiving poorly-matched cadaver kidneys do far less well than patients receiving mismatched related grafts, however, even when ALG is utilized.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. The 12th Report of the Human Renal Transplant Registry. Prepared by the Advisory Committee to the Renal Transplant Registry.
        JAMA. 1975; 233: 787
        • Simmons RL
        • Kjellstrand CM
        • Najarian JS
        Kidney: technique, complications and results.
        in: Najarian JS Simmons RL Transplantation. Lea & Febiger, Philadelphia1972
        • Najarian JS
        • Simmons RL
        The clinical use of antilymphocyte globulin.
        N Engl J Med. 1971; 285: 154
        • Callender CO
        • Simmons RL
        • Yunis EJ
        • et al.
        Anti-HL-A antibodies. Failure to correlate with renal allograft rejection.
        Surgery. 1974; 76: 573
        • Rappaport FT
        • Dausset J
        Ranks of donor-recipient histocompatibility for human transplantation.
        Science. 1969; 167: 1260
        • Merrell M
        • Shulman LE
        Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus.
        J Chronic Dis. 1955; 6: 12
        • Kjellstrand CM
        • Simmons RL
        • Goetz FC
        • et al.
        Renal transplantation in patients with insulin-dependent diabetes.
        Lancet. 1973; 2: 4
        • Najarian JS
        • Kjellstrand CM
        • Simmons RL
        • et al.
        Renal transplantation for diabetic glomerulosclerosis.
        Ann Surg. 1973; 178: 477
      2. The 11th Report of the uman Renal Transplant Registry. Prepared by the Advisory Committee to the Renal Transplant Registry.
        JAMA. 1973; 226: 1197
        • Simmons RL
        • Kjellstrand CM
        • Buselmeier TJ
        • et al.
        Renal transplantation in high-risk patients.
        Arch Surg. 1971; 103: 290
        • Woods JE
        • Anderson CF
        • Johnson WJ
        • et al.
        Experience with renal transplantation in high risk patients.
        Surg Gynecol Obstet. 1973; 137: 393
        • Delmonico FL
        • Cosimi AB
        • Russell PE
        Renal transplantation in the older age group.
        Arch Surg. 1975; 110: 1107
        • Desnick RJ
        • Simmons RL
        • Allen KY
        • et al.
        Correction of enzymatic deficiencies by renal transplantation. Fabry's disease.
        Surgery. 1972; 72: 203
        • Markland C
        • Kelly WD
        • Buselmeier TJ
        • et al.
        Renal transplantation into ileac urinary conduits.
        in: 3rd ed. Transplant Proc. 4. 1972: 629
        • Dausset J
        • Hors J
        • Busson J
        • et al.
        Serologically defined HL-A antigens and long-term survival of cadaver kidney transplants.
        N Engl J Med. 1974; 290: 979
        • Dausset J
        • Hors J
        • Busson M
        Histocompatibility and kidney transplantation (within the France-Transplant network).
        in: VIth Int'l. Congress of Nephrol, Florence1975
        • Dausset J
        • Hors J
        Analysis of 221 renal transplants. Influence of cross-reactions between donor and recipient HL-A antigens.
        in: 3rd ed. Transplant Proc. 3. 1971: 1004
        • Belzer FO
        • Fortmann JL
        • Salvatierra O
        • et al.
        Is HL-A typing of clinical significance in cadaver renal transplantation?.
        Lancet. 1974; 1: 774
        • Opelz G
        • Mickey MR
        • Terasaki PI
        HL-A and kidney transplants. Re-examination.
        Transplantation. 1974; 17: 371
        • Simmons RL
        • Moberg AW
        • Gewurz H
        • et al.
        Immunosuppressive assay of antilymphoblast globulin in man. Effect of dose, histocompatibility and serologic response to horse gamma globulin.
        Surgery. 1970; 68: 62
        • Condie RM
        • White JG
        • Najarian JS
        Platelet activity of antilymphocyte serum preparations.
        in: 3rd ed. Transplant Proc. 5. 1973: 555
        • Lopez C
        • Simmons RL
        • Touraine JL
        • et al.
        Discrepancy between PHA responsiveness and quantitative estimates of T-cell numbers in human peripheral blood during chronic renal failure and immunosuppression after transplantation.
        Clin Immunol Immunopathol. 1975; 4: 135
        • Martin W
        • Blumenthal M
        • Roitman B
        • et al.
        Anti-lymphoblast globulin in renal transplant patients. No allergic reactions.
        JAMA. 1976; 236: 1729
        • Sheil AGR
        • Mears D
        • Johnson JR
        • et al.
        Antilymphocyte globulin in patients with renal allografts from cadaveric donors. Late results of a controlled trial.
        Lancet. 1973; 2: 227
        • Turcotte JG
        • Feduska NJ
        • Naines RF
        • et al.
        A clinical trial of antithymocyto globulin in renal transplant recipients.
        Arch Surg. 1973; 106: 484
        • Mannick JA
        • Davis RC
        • Cooperband SR
        • et al.
        Clinical use of rabbit antihuman lymphocyte globulin in cadaver-kidney transplantation.
        N Engl J Med. 1971; 284: 1109
        • Kashiwagi N
        • Brantigan CO
        • Brettschneider L
        • et al.
        Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts.
        Ann Intern Med. 1968; 68: 275
        • Diethelm AG
        • Aldrete JS
        • Shaw JF
        • et al.
        Clinical evaluation of equine antithymocyte globulin in recipients of renal allografts. Analysis of survival, renal function, rejection, histocompatibility and complications.
        Ann Surg. 1974; 180: 20
      3. Simmons RL, Thompson EJ, Yunis EJ, et al.: 100 sibling kidney transplants followed 2 to 7.5 years. A multifactorial analysis. Ann Surg (in press).

        • Simmons RL
        • Thompson EJ
        • Yunis EJ
        • et al.
        Parent-to-child and child-to-parent kidney transplants. Experience with 101 transplants at one centre.
        Lancet. 1976; 1: 321
        • Kjellstrand CM
        • Simmons RL
        • Buselmeier TJ
        • et al.
        Renal transplantation at the University of Minnesota 1968–1973.
        Minn Med. 1974; 57: 886
        • Samuels S
        • Charra B
        • Olheiser K
        • et al.
        Twelve years' experience of treatment of chronic renal failure.
        Trans Am Soc Artif Int Organs. 1974; 20: 62
        • Kjellstrand CM
        • Shideman BS
        • Lynch R
        • et al.
        Transplantation in the geriatric patient.
        Geriatrics. 1976; 31: 65
        • Toledo-Pereyra LH
        • Simmons RL
        • Moberg AW
        • et al.
        Organ preservation in success of cadaver transplants.
        Arch Surg. 1975; 110: 1031
        • Toledo-Pereyra LH
        • Simmons RL
        • Moberg AW
        • et al.
        Perfusion time and the survival of cadaver transplants.
        Surgery. 1976; 79: 377